SCHEMBL5795129

SCHEMBL5795129

COc1cc2c(-c3ccc[nH]3)cn(CCN3CCN(C)CC3)c2cc1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.42
KDR P35968 3/20 0.42
FLT3 P36888 1/20 0.39
IGF1R P08069 1/20 0.37
HTR7 P34969 1/20 0.36
CHEK1 O14757 2/20 0.36
DRD2 P14416 3/20 0.36
DRD3 P35462 2/20 0.36
HTR1A P08908 2/20 0.36
SLC6A2 P23975 2/20 0.36
HTR2A P28223 2/20 0.36
SLC6A3 Q01959 2/20 0.36
SLC6A4 P31645 1/20 0.36
CNR1 P21554 2/20 0.35
HTR6 P50406 1/20 0.35
DRD4 P21917 1/20 0.34
HRH2 P25021 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
MAP4K1 Q92918 1/20 0.34
CDK2 P24941 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5794589 0.90 KDR (0.46) GSK3BKDRFLT3HTR7DRD2
SCHEMBL5798073 0.83 IGF1R (0.45) KDRIGF1RCHEK1HTR2C
SCHEMBL5794484 0.83 IGF1R (0.40) GSK3BIGF1RTP53
SCHEMBL5794491 0.82 GSK3B (0.39) GSK3BKDRFLT3IGF1RHTR7
SCHEMBL5795213 0.82 KDR (0.37) GSK3BKDRFLT3IGF1RHTR7
SCHEMBL5794829 0.81 IGF1R (0.39) GSK3BKDRFLT3IGF1RDRD2
SCHEMBL5795654 0.79 QPCT (0.34) GSK3BKDRFLT3IGF1RCHEK1
SCHEMBL1749006 0.78 IGF1R (0.67) GSK3BKDRIGF1RDRD2DRD3
SCHEMBL5793291 0.77 IGF1R (0.56) GSK3BKDRFLT3IGF1RCDK2
SCHEMBL5796367 0.76 BRD4 (0.45) KDRIGF1RCHEK1HTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732546-A2 NOVEL PYRROLO (2,3-B)PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS Aventis Pharma S.A. (FR) 2006-12-20 EP disclosed
WO-2005095399-A2 NOVEL PYRROLO (2,3-B)PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2005-10-13 WO disclosed